Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The angiotensin II receptors are a family of G protein-coupled receptors that mediate the effects of angiotensin II, a key hormone in the renin-angiotensin system (RAS). The most well-characterized subtypes are AT1 and AT2, which have opposing effects on blood pressure, cell growth, and other physiological processes. AT1 receptor activation leads to vasoconstriction, aldosterone release, and cell proliferation, while AT2 receptor activation generally opposes these effects, promoting vasodilation, antiproliferation, and neuronal regeneration. Angiotensin II receptors, especially AT1, are major drug targets for managing hypertension and heart failure.
ARBs block the binding of angiotensin II to the AT1 receptor, preventing vasoconstriction, aldosterone release, and other downstream effects of angiotensin II signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiotensin II Receptor (None).